Overall Status

Active, not recruiting (1)

Not yet recruiting (1)

Sign in for free

Phase

phase 1 (1)

phase 2 (1)

Sponsor

Peloton Therapeutics, Inc. (1)

University of Illinois at Chicago (1)

Collaborator

Intervention

belzutifan (1)

digoxin (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (1)

Other (1)

Study Type

Interventional (2)

vhl gene mutation

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

VHL - Von Hippel-Lindau Syndrome, VHL Gene Mutation, VHL Syndrome Trial in Worldwide (Belzutifan)

Active, not recruiting

VHL - Von Hippel-Lindau Syndrome
+5 more

Belzutifan

Bethesda, Maryland
+10 more

Aug 16, 2022

Polycythemia; Familial, Erythrocytosis; Familial, VHL Gene Mutation Trial (Digoxin)

Not yet recruiting

Polycythemia; Familial
+5 more

Digoxin

(no location specified)

Feb 2, 2022